Linc AB (STO:LINC)

Sweden flag Sweden · Delayed Price · Currency is SEK
65.70
-0.90 (-1.35%)
Feb 10, 2026, 5:29 PM CET
Market Cap3.86B -16.2%
Revenue (ttm)-414.00M
Net Income-399.65M
EPS-6.90
Shares Out57.91M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume52,033
Average Volume75,745
Open66.70
Previous Close66.60
Day's Range65.20 - 67.20
52-Week Range58.90 - 83.60
Beta0.76
RSI55.29
Earnings DateJan 22, 2026

About Linc AB

Linc AB is a private equity and venture capital firm, specializing in early and mature stage investments in pharmaceutical, life-science and med-tech companies. It prefers to invest in drug development usually take place at an early stage, while investments in medical technology are made in more mature businesses. The investments are made in both private and public companies and in research and operational companies. The firm prefers to invest in Nordic companies. It usually invests from SEK 25 million ($2.99 million) and SEK 250 million ($29.9... [Read more]

Sector Financials
Founded 1991
Employees 2
Stock Exchange Nasdaq Stockholm
Ticker Symbol LINC
Full Company Profile

Financial Performance

Financial Statements